-
公开(公告)号:US20130231329A1
公开(公告)日:2013-09-05
申请号:US13825989
申请日:2011-09-27
申请人: Isabelle Berrebi-Bertrand , Xavier Billot , Thierry Calmels , Marc Capet , Denis Danvy , Stéphane Krief , Olivier Labeeuw , Jeanne-Marie Lecomte , Nicolas Levoin , Xavier Ligneau , Philippe Robert , Jean-Charles Schwartz
发明人: Isabelle Berrebi-Bertrand , Xavier Billot , Thierry Calmels , Marc Capet , Denis Danvy , Stéphane Krief , Olivier Labeeuw , Jeanne-Marie Lecomte , Nicolas Levoin , Xavier Ligneau , Philippe Robert , Jean-Charles Schwartz
IPC分类号: C07D417/12 , C07D401/12 , C07D401/14 , A61K31/5377 , A61K31/454 , A61K31/428 , A61K31/4545 , A61K31/496 , C07D417/14 , A61K45/06
CPC分类号: C07D417/14 , A61K31/428 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D417/04 , C07D417/12
摘要: The present patent application concerns new ligands of the H4-receptor of formula (I), their process of preparation and their therapeutic use.
摘要翻译: 本专利申请涉及式(I)的H 4受体的新配体,其制备方法及其治疗用途。
-
公开(公告)号:US08802664B2
公开(公告)日:2014-08-12
申请号:US13825989
申请日:2011-09-27
申请人: Isabelle Berrebi-Bertrand , Xavier Billot , Thierry Calmels , Marc Capet , Denis Danvy , Stephane Krief , Olivier Labeeuw , Jeanne-Marie Lecomte , Nicolas Levoin , Xavier Ligneau , Philippe Robert , Jean-Charles Schwartz
发明人: Isabelle Berrebi-Bertrand , Xavier Billot , Thierry Calmels , Marc Capet , Denis Danvy , Stephane Krief , Olivier Labeeuw , Jeanne-Marie Lecomte , Nicolas Levoin , Xavier Ligneau , Philippe Robert , Jean-Charles Schwartz
IPC分类号: C07D417/12 , C07D401/12 , C07D401/14 , A61K31/5377 , A61K31/454 , A61K31/428
CPC分类号: C07D417/14 , A61K31/428 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D417/04 , C07D417/12
摘要: The present patent application concerns new ligands of the H4-receptor of formula (I), their process of preparation and their therapeutic use.
摘要翻译: 本专利申请涉及式(I)的H 4受体的新配体,其制备方法及其治疗用途。
-
3.
公开(公告)号:US08802678B2
公开(公告)日:2014-08-12
申请号:US12306044
申请日:2007-06-21
申请人: Marc Capet , Denis Danvy , Nicolas Levoin , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jeanne-Marie Lecomte , Jean-Charles Schwartz , Xavier Ligneau
发明人: Marc Capet , Denis Danvy , Nicolas Levoin , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jeanne-Marie Lecomte , Jean-Charles Schwartz , Xavier Ligneau
IPC分类号: A61K31/497 , A61K31/4965 , C07D401/06 , C07D413/06 , C07D403/06
CPC分类号: C07D213/74 , C07D211/26 , C07D211/60 , C07D211/70 , C07D215/40 , C07D217/02 , C07D239/42 , C07D295/10 , C07D295/112 , C07D295/135 , C07D295/14 , C07D295/155 , C07D307/24
摘要: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.
摘要翻译: 本发明涉及通式(I)的化合物:其制备方法及其作为治疗剂的用途。
-
4.CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS 有权
标题翻译: 碳酸化(AZA)环己烷作为DOPAMINE D3受体配体公开(公告)号:US20090286801A1
公开(公告)日:2009-11-19
申请号:US12306044
申请日:2007-06-21
申请人: Marc Capet , Denis Danvy , Nicolas Levoin , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jeanne-Marie Lecomte , Jean-Charles Schwartz , Xavier Ligneau
发明人: Marc Capet , Denis Danvy , Nicolas Levoin , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jeanne-Marie Lecomte , Jean-Charles Schwartz , Xavier Ligneau
IPC分类号: A61K31/496 , C07D241/04 , C07D401/06 , C07D403/04 , C07D401/10 , A61P25/00
CPC分类号: C07D213/74 , C07D211/26 , C07D211/60 , C07D211/70 , C07D215/40 , C07D217/02 , C07D239/42 , C07D295/10 , C07D295/112 , C07D295/135 , C07D295/14 , C07D295/155 , C07D307/24
摘要: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.
摘要翻译: 本发明涉及通式(I)的化合物:其制备方法及其作为治疗剂的用途。
-
公开(公告)号:US20080167320A1
公开(公告)日:2008-07-10
申请号:US12044243
申请日:2008-03-07
申请人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
发明人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
IPC分类号: A61K31/497 , C07D401/02 , A61P15/10 , A61P25/28 , C07D401/14
CPC分类号: C07D217/22 , C07D215/38
摘要: Compounds of the general formula (I) below: are provided along with a process for preparing them, and these compounds may be used as therapeutic agents, e.g., for prevention and/or treatment of a neuropsychiatric illness or any illness involving the dopamine D3 receptor.
摘要翻译: 以下通式(I)的化合物与其制备方法一起提供,并且这些化合物可用作治疗剂,例如用于预防和/或治疗神经精神疾病或涉及多巴胺D3受体的任何疾病 。
-
6.Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents 失效
标题翻译: 芳基哌嗪衍生物,其生产方法及其作为治疗剂的用途公开(公告)号:US07432269B2
公开(公告)日:2008-10-07
申请号:US11252870
申请日:2005-10-19
申请人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
发明人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
IPC分类号: A61K31/497 , C07D401/00 , C07D413/00 , C07D417/00
CPC分类号: C07D217/22 , C07D215/38
摘要: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent having the property of being selective ligands for the dopamine D3 receptor. These selective D3 ligands are useful as medicines in neuropsychiatry, in particular in the treatment of psychotic or depressive states, or in the treatment of motor disorders, such as dyskinesia or essential tremor. They are furthermore useful in the treatment of dependency on nicotine, cocaine, alcohol, opioids and for facilitating withdrawal in drug-dependent individuals.
摘要翻译: 本发明涉及通式(I)的化合物:其制备方法及其作为具有作为多巴胺D3受体的选择性配体的性质的治疗剂的用途。 这些选择性D3配体可用作神经精神病学中的药物,特别是用于治疗精神病或抑郁状态,或用于治疗运动障碍,例如运动障碍或原发性震颤。 它们还可用于治疗对尼古丁,可卡因,酒精,阿片样物质的依赖,并有利于药物依赖个体的戒断。
-
7.Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands 审中-公开
标题翻译: 芳基哌嗪衍生物及其作为选择性多巴胺D3受体配体的用途公开(公告)号:US20080214542A1
公开(公告)日:2008-09-04
申请号:US11720526
申请日:2005-11-29
申请人: Marc Capet , Denis Danvy , Catherine Dartois , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
发明人: Marc Capet , Denis Danvy , Catherine Dartois , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
IPC分类号: A61K31/496 , C07D403/06 , C07D413/14 , A61K31/454 , A61P25/00 , A61K31/5377 , C07D401/06
CPC分类号: C07D209/44 , C07D405/12
摘要: The invention concerns compounds of general formula (I), a method for preparing same, as well as their use as therapeutic agent.
摘要翻译: 本发明涉及通式(I)的化合物,其制备方法及其作为治疗剂的用途。
-
8.Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents 失效
标题翻译: 芳基哌嗪衍生物,其生产方法及其作为治疗剂的用途公开(公告)号:US20060089364A1
公开(公告)日:2006-04-27
申请号:US11252870
申请日:2005-10-19
申请人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
发明人: Marc Capet , Denis Danvy , Nicolas Levoin , Marcel Morvan , Isabelle Berrebi-Bertrand , Thierry Calmels , Philippe Robert , Jean-Charles Schwartz , Jeanne-Marie Lecomte
IPC分类号: A61K31/496 , C07D417/02 , C07D413/02 , C07D403/02
CPC分类号: C07D217/22 , C07D215/38
摘要: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.
摘要翻译: 本发明涉及通式(I)的化合物:其制备方法及其作为治疗剂的用途。
-
9.Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them 失效
标题翻译: 法霉素的多形态,其制备方法和包含它们的药物组合物公开(公告)号:US06767921B2
公开(公告)日:2004-07-27
申请号:US10396692
申请日:2003-03-26
申请人: Marc Capet , Gérard Coquerel , Denis Danvy , Jeanne-Marie Lecomte , Marie-Noëlle Petit , Jean-Charles Schwartz
发明人: Marc Capet , Gérard Coquerel , Denis Danvy , Jeanne-Marie Lecomte , Marie-Noëlle Petit , Jean-Charles Schwartz
IPC分类号: A61K3136
CPC分类号: C07D317/60
摘要: The subject of the present invention is the various polymorphic forms I, II, III, IV of benzyl (S,S)-2-(2-acetylsulphanylmethyl-3-benzo[1,3]dioxol-5-ylpropionyl-amino)propionate, hereinafter called Fasidotril, their methods of preparation and novel pharmaceutical compositions containing them.
摘要翻译: 本发明的主题是(S,S)-2-(2-乙酰基硫烷基甲基-3-苯并[1,3]间二氧杂环戊烯-5-基丙酰基 - 氨基)丙酸苄酯的各种多晶型I,II,III,IV ,以下称为Fasidotril,其制备方法和含有它们的新型药物组合物。
-
公开(公告)号:US06436973B1
公开(公告)日:2002-08-20
申请号:US09787708
申请日:2001-06-11
申请人: Denis Danvy , Thierry Monteil , Jean-Christophe Plaquevent , Pierre Duhamel , Lucette Duhamel , Nadine Noel , Claude Gros , Olivier Chamard , Jean-Charles Schwartz , Jeanne-Marie Lecomte
发明人: Denis Danvy , Thierry Monteil , Jean-Christophe Plaquevent , Pierre Duhamel , Lucette Duhamel , Nadine Noel , Claude Gros , Olivier Chamard , Jean-Charles Schwartz , Jeanne-Marie Lecomte
IPC分类号: C07D21364
CPC分类号: C07C323/25 , C07C327/30 , C07D213/64 , C07D317/64
摘要: The invention concerns LTA4 hydrolase inhibiting compositions of formula (1) as set forth below. It also concerns their therapeutic, in particular anti-inflammatory, applications.
摘要翻译: 本发明涉及如下所述的式(1)的LTA4水解酶抑制组合物。 它还涉及其治疗,特别是抗炎的应用。
-
-
-
-
-
-
-
-
-